MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$4,734K
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
2,077
1,459
1,441*
249
General and administrative
2,525
2,169
-1,246*
1,975
Impairment loss on other intangible assets
-
3,700
1,295*
-
Impairment loss on goodwill
-
8,430
-
-
Impairment loss on other intangible assets
-
-
-
5,180
Total operating expenses
-
15,758
1,490
-
Loss from operations
-4,602
-15,758
-1,490*
-7,404
Interest income
-
-
-0*
1
Interest expense
80
61
660*
121
Gain on settlement of current liabilities
-
167
38*
774
Loss on debt extinguishment
-
-
-263*
-967
Change in fair value of warrant liabilities
-99
44
195*
253
Gain on derivative liability
-
-
70*
-100
Change in fair value of derivative liability
-
230
-
-
Foreign currency exchange gain (loss), net
-26
64
-482*
76
Total other income (expense), net
-205
444
-1,103*
-84
Net gain before tax
-4,807
-15,314
-2,594*
-7,488
Benefit from deferred income taxes
-
-859
2,261*
-1,088
Net loss
-4,807
-14,455
-4,855*
-6,400
Foreign currency translation adjustment
73
14
513
-38
Total other comprehensive (gain) income, net of tax
73
14
513*
-38
Total comprehensive loss
-4,734
-14,441
-4,343
-6,438
Basic EPS
0
0
-0
0
Diluted EPS
0
0
-0
0
Basic Average Shares
143,317,469,445
118,757,013,401
73,714,253,551
65,326,236,698
Diluted Average Shares
143,317,469,445
118,757,013,401
73,714,253,551
65,326,236,698
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Foreign currency
translation adjustment
$73K
(121.92%↑ Y/Y)
Total comprehensive
loss
-$4,734K
(-112.48%↓ Y/Y)
Total other
comprehensive (gain) income,...
$73K
(121.92%↑ Y/Y)
Net loss
-$4,807K
(-153.67%↓ Y/Y)
Net gain before tax
-$4,807K
Loss from operations
-$4,602K
(-47.55%↓ Y/Y)
Total other income
(expense), net
-$205K
(-116.75%↓ Y/Y)
General and
administrative
$2,525K
(2.98%↑ Y/Y)
Research and development
$2,077K
(211.39%↑ Y/Y)
Change in fair value of
warrant liabilities
-$99K
(-173.88%↓ Y/Y)
Interest expense
$80K
(60.00%↑ Y/Y)
Foreign currency
exchange gain (loss), net
-$26K
(48.00%↑ Y/Y)
Buy us a coffee
Akari Therapeutics Plc (AKTX)
Akari Therapeutics Plc (AKTX)